InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2022-12-02 00:00:00 ET · period of report 2022-11-30 · accession 0001415889-22-011973 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-02 2022-11-30 ELAN HOOVER R DAVID Dir A - Grant $0.00 +18.6K 57.9K +47% $0
D 2022-12-02 2022-11-30 ELAN HOOVER R DAVID Dir A - Grant $12.87 +828.80 25.9K +3% +$10.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-30 A A 18,649 $0.00 57,916 D — — (F1) Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
2 Derivative Deferred Stock Units 2022-11-30 A A 828.80 $12.87 25,947.58 D — · — to — 828.80 Common Stock (F2) Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. (F3) The Deferred Stock Units will be settled in stock following the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. (F4) The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $12.87 on November 30, 2022.